Novel compound heterozygous mutations in a child with Ataxia-Telangiectasia showing unrelated cerebellar disorders

[1]  Sang-Hoon Seol,et al.  Childhood colon cancer in a patient with ataxia telangiectasia. , 2016, Annals of translational medicine.

[2]  T. Kipps,et al.  ATM Mutations in Cancer: Therapeutic Implications , 2016, Molecular Cancer Therapeutics.

[3]  G. Dianov,et al.  ATM prevents DSB formation by coordinating SSB repair and cell cycle progression , 2015, Proceedings of the National Academy of Sciences.

[4]  P. Byrd,et al.  Ataxia telangiectasia: more variation at clinical and cellular levels , 2015, Clinical genetics.

[5]  A. Fischer,et al.  Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Y. Shiloh.  ATM: expanding roles as a chief guardian of genome stability. , 2014, Experimental cell research.

[7]  R. Al-Baradie,et al.  Ataxia-telangiectasia: future prospects , 2014, The application of clinical genetics.

[8]  D. Cochrane,et al.  Neurological morbidity of surgical resection of pediatric cerebellar astrocytomas , 2013, Child's Nervous System.

[9]  D. Easton,et al.  Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours , 2011, British Journal of Cancer.

[10]  G. Tsangaris,et al.  The ATM gene and ataxia telangiectasia. , 2008, Anticancer research.

[11]  A. Masri,et al.  Ataxia-telangiectasia complicated by craniopharyngioma--a new observation. , 2006, Pediatric neurology.

[12]  M. Naito,et al.  Astrocytoma linked to familial ataxia-telangiectasia , 2006, Acta Neurochirurgica.

[13]  P. Byrd,et al.  Molecular pathology of ataxia telangiectasia , 2005, Journal of Clinical Pathology.

[14]  A. Børresen-Dale,et al.  Designing and implementing quality control for multi‐center screening of mutations in the ATM gene among women with breast cancer , 2003, Human mutation.

[15]  M. Meyn.  Ataxia‐telangiectasia, cancer and the pathobiology of the ATM gene , 1999, Clinical genetics.

[16]  M. Swift,et al.  Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. , 1986, Journal of the National Cancer Institute.

[17]  E. Boder.  Ataxia-telangiectasia: an overview. , 1985, Kroc Foundation series.

[18]  J. Perrin.  C3 STANDARDS , 1975, The Lancet.

[19]  R. Good,et al.  ATAXIA-TELANGIECTASIA. ITS ASSOCIATION WITH A DEFECTIVE THYMUS, IMMUNOLOGICAL-DEFICIENCY DISEASE, AND MALIGNANCY. , 1964, Lancet.